A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT06512428 · UNKNOWN
Trial details
- NCT number
- NCT06512428
- Sponsor
- Shanghai Runshi Pharmaceutical Technology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-15
- Primary completion
- 2026-01-30
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.